Sign in
4/A

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-22-000020

Chief Financial Officer bought 121 shares at $2.09 ($253)

From the SEC's structured data for this filing

Trades in this filing

Downey Gregory · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-10-14 Purchase : show line 1 in the form +121 $2.09 $253 1,954 D
Open-market purchases · 121 sh · avg $2.09 · $253
Loading xslF345X03/primary_doc.xml…